Quick Answer
Nu-Med Plus, Inc. reported Diluted EPS of $0.00 per share for fiscal year 2024.
Nu-Med Plus, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | $0.00 | — |
| 2023 | $0.00 | — |
| 2022 | $0.00 | +100.0% |
| 2021 | -$0.01 | +66.7% |
| 2018 | -$0.03 | -160.0% |
| 2017 | $0.05 | -61.5% |
| 2016 | $0.13 | +152.0% |
| 2015 | -$0.25 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | — | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | — | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
- Over the 2015–2024 period, Nu-Med Plus, Inc.’s diluted eps has grown by 100.0% (from $0.25 per share (loss) to $0.00 per share).
- The most recent figure is from Nu-Med Plus, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: